Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1985 | 1 |
2007 | 1 |
2008 | 1 |
2017 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Seladelpar efficacy and safety at 3 months in patients with primary biliary cholangitis: ENHANCE, a phase 3, randomized, placebo-controlled study.
Hepatology. 2023 Aug 1;78(2):397-415. doi: 10.1097/HEP.0000000000000395. Epub 2023 Apr 6.
Hepatology. 2023.
PMID: 37386786
Free PMC article.
Clinical Trial.
A phase II, randomized, open-label, 52-week study of seladelpar in patients with primary biliary cholangitis.
Bowlus CL, Galambos MR, Aspinall RJ, Hirschfield GM, Jones DEJ, Dörffel Y, Gordon SC, Harrison SA, Kremer AE, Mayo MJ, Thuluvath PJ, Levy C, Swain MG, Neff GW, Sheridan DA, Stanca CM, Berg CP, Goel A, Shiffman ML, Vierling JM, Boudes P, Steinberg A, Choi YJ, McWherter CA.
Bowlus CL, et al. Among authors: galambos mr.
J Hepatol. 2022 Aug;77(2):353-364. doi: 10.1016/j.jhep.2022.02.033. Epub 2022 Mar 30.
J Hepatol. 2022.
PMID: 35367282
Free article.
Clinical Trial.
Item in Clipboard
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.
Jones D, Boudes PF, Swain MG, Bowlus CL, Galambos MR, Bacon BR, Doerffel Y, Gitlin N, Gordon SC, Odin JA, Sheridan D, Wörns MA, Clark V, Corless L, Hartmann H, Jonas ME, Kremer AE, Mells GF, Buggisch P, Freilich BL, Levy C, Vierling JM, Bernstein DE, Hartleb M, Janczewska E, Rochling F, Shah H, Shiffman ML, Smith JH, Choi YJ, Steinberg A, Varga M, Chera H, Martin R, McWherter CA, Hirschfield GM.
Jones D, et al. Among authors: galambos mr.
Lancet Gastroenterol Hepatol. 2017 Oct;2(10):716-726. doi: 10.1016/S2468-1253(17)30246-7. Epub 2017 Aug 14.
Lancet Gastroenterol Hepatol. 2017.
PMID: 28818518
Clinical Trial.
Item in Clipboard
Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.
Mayo MJ, Vierling JM, Bowlus CL, Levy C, Hirschfield GM, Neff GW, Galambos MR, Gordon SC, Borg BB, Harrison SA, Thuluvath PJ, Goel A, Shiffman ML, Swain MG, Jones DEJ, Trivedi P, Kremer AE, Aspinall RJ, Sheridan DA, Dörffel Y, Yang K, Choi YJ, McWherter CA.
Mayo MJ, et al. Among authors: galambos mr.
Aliment Pharmacol Ther. 2024 Jan;59(2):186-200. doi: 10.1111/apt.17755. Epub 2023 Oct 30.
Aliment Pharmacol Ther. 2024.
PMID: 37904314
Item in Clipboard
Are colonoscopies performed in private offices less likely to be successful?
Rubin RA, Galambos MR.
Rubin RA, et al. Among authors: galambos mr.
Gastroenterology. 2007 Oct;133(4):1390; author reply 1392. doi: 10.1053/j.gastro.2007.08.033.
Gastroenterology. 2007.
PMID: 17919516
No abstract available.
Item in Clipboard
A radioimmunoassay procedure for type III procollagen: its use in the detection of hepatic fibrosis.
Galambos MR, Collins DC, Galambos JT.
Galambos MR, et al.
Hepatology. 1985 Jan-Feb;5(1):38-42. doi: 10.1002/hep.1840050109.
Hepatology. 1985.
PMID: 3967864
Item in Clipboard
Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection.
Saifee S, Joelson D, Braude J, Shrestha R, Johnson M, Sellers M, Galambos MR, Rubin RA.
Saifee S, et al. Among authors: galambos mr.
Clin Gastroenterol Hepatol. 2008 Oct;6(10):1167-9. doi: 10.1016/j.cgh.2008.04.023. Epub 2008 Jul 17.
Clin Gastroenterol Hepatol. 2008.
PMID: 18639498
Item in Clipboard
Cite
Cite